Company / Accounts Receivable
STANDARD BIOTOOLS INC. Accounts Receivable History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$13.4M
FY2025
5-year range
$13.4M / $33.6M
FY2021-FY2025
Trend
-60.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Accounts Receivable has fluctuated over the past 10 years, ranging from $13M in FY2025 to $34M in FY2024.
Based on SEC 10-K filings.
$13M in FY2025 with a 5-year CAGR of -12.0%.
Declined from $20M to $13M over the past 2 years.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- -8.1%
- 5-Year CAGR
- -12.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -12.0%, indicating a declining trend.
- In FY2025, accounts receivable decreased 60.0% year-over-year.
- Peak accounts receivable was recorded in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $13.4M | -60.0% |
| FY2024 | $33.6M | +70.9% |
| FY2023 | $19.7M | +13.8% |
| FY2022 | $17.3M | -5.7% |
| FY2021 | $18.3M | -27.9% |
| FY2020 | $25.4M | +33.9% |
| FY2019 | $19.0M | +14.0% |
| FY2018 | $16.7M | +10.6% |
| FY2017 | $15.0M | +3.0% |
| FY2016 | $14.6M | -42.6% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026